Payment overview · 2025
General Payments
$137.08
7 reported records · 6 companies
Healthcare provider profile · identity verified
Vahid-David Sedaghat, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · FORT WAYNE, IN · NPI 1972584043
Verified facts
What the public records show
CMS Open Payments records show Vahid-David Sedaghat, M.D. received $137.08 in general payments during 2025 across 7 reported records.
Vanda Pharmaceuticals Inc. accounted for 25.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ARMOUR THYROID as an associated drug or biological on 50 records involving 11 distinct recipient NPIs. Public Medicare Part D data also shows 24 claims for Armour Thyroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 19 claims for Synthroid by this doctor in 2024.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 358 claims for Jardiance by this doctor in 2024.
E.R. Squibb & Sons, L.L.C. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 27956 records involving 14870 distinct recipient NPIs. Public Medicare Part D data also shows 2276 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Vanda Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $35.36 | 25.8% | 2 | 2025 |
| Merck Sharp & Dohme LLC | Unresolved — no canonical attribution shown | $22.98 | 16.8% | 1 | 2025 |
| E.R. Squibb & Sons, L.L.C. | Unresolved — no canonical attribution shown | $20.96 | 15.3% | 1 | 2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $20.84 | 15.2% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $18.94 | 13.8% | 1 | 2025 |
| Echosens North America, Inc. | Unresolved — no canonical attribution shown | $18.00 | 13.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $137.08 | 7 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FANAPT Normalized: fanapt |
Drug | Vanda Pharmaceuticals Inc. | $35.36 | 2 | 2025 |
Source payment records
|
|||||
| WINREVAIR Normalized: winrevair |
Biological | Merck Sharp & Dohme LLC | $22.98 | 1 | 2025 |
Source payment records
|
|||||
| CAMZYOS Normalized: camzyos |
Drug | E.R. Squibb & Sons, L.L.C. | $20.96 | 1 | 2025 |
Source payment records
|
|||||
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $18.94 | 1 | 2025 |
Source payment records
|
|||||
| Fibroscan Normalized: fibroscan |
Device | Echosens North America, Inc. | $18.00 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | ARMOUR THYROID open payments reported associated product |
CMS Open Payments — General Payments 50 supporting records · 11 recipient NPIs · example record 1201517088 |
Armour Thyroid · 2024 Exact normalized brand match · 1 Part D row |
24 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
19 | suppressed by CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
358 | 30 |
| E.R. Squibb & Sons, L.L.C. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 27956 supporting records · 14870 recipient NPIs · example record 1184377713 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
2276 | 163 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 2884 | 276 |
| Furosemide | Furosemide | 2427 | 209 |
| Eliquis | Apixaban | 2276 | 163 |
| Levothyroxine Sodium | Levothyroxine Sodium | 2184 | 172 |
| Amlodipine Besylate | Amlodipine Besylate | 2110 | 177 |
| Gabapentin | Gabapentin | 1991 | 159 |
| Potassium Chloride | Potassium Chloride | 1671 | 145 |
| Metformin Hcl | Metformin Hcl | 1565 | 101 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1550 | 138 |
| Metoprolol Succinate | Metoprolol Succinate | 1519 | 122 |
| Omeprazole | Omeprazole | 1484 | 133 |
| Tamsulosin Hcl | Tamsulosin Hcl | 1308 | 106 |
| Sertraline Hcl | Sertraline Hcl | 1182 | 84 |
| Lisinopril | Lisinopril | 1143 | 104 |
| Clopidogrel | Clopidogrel Bisulfate | 974 | 72 |
| Donepezil Hcl | Donepezil Hcl | 965 | 67 |
| Metoprolol Tartrate | Metoprolol Tartrate | 911 | 100 |
| Memantine Hcl | Memantine Hcl | 908 | 50 |
| Carvedilol | Carvedilol | 833 | 85 |
| Ropinirole Hcl | Ropinirole Hcl | 812 | 54 |
| Losartan Potassium | Losartan Potassium | 788 | 78 |
| Buspirone Hcl | Buspirone Hcl | 786 | 67 |
| Trazodone Hcl | Trazodone Hcl | 679 | 64 |
| Escitalopram Oxalate | Escitalopram Oxalate | 568 | 57 |
| Torsemide | Torsemide | 526 | 51 |
| Fluoxetine Hcl | Fluoxetine Hcl | 434 | 28 |
| Levetiracetam | Levetiracetam | 420 | 27 |
| Hydralazine Hcl | Hydralazine Hcl | 418 | 27 |
| Quetiapine Fumarate | Quetiapine Fumarate | 406 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 403 | 33 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 395 | 23 |
| Allopurinol | Allopurinol | 386 | 39 |
| Citalopram Hbr | Citalopram Hydrobromide | 366 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 361 | 53 |
| Jardiance | Empagliflozin | 358 | 30 |
| Famotidine | Famotidine | 357 | 38 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 313 | 49 |
| Finasteride | Finasteride | 310 | 22 |
| Spironolactone | Spironolactone | 305 | 33 |
| Bumetanide | Bumetanide | 295 | 20 |
| Gemtesa | Vibegron | 272 | 18 |
| Montelukast Sodium | Montelukast Sodium | 271 | 44 |
| Mirtazapine | Mirtazapine | 250 | 36 |
| Tradjenta | Linagliptin | 250 | 12 |
| Digoxin | Digoxin | 247 | 18 |
| Prednisone | Prednisone | 241 | 50 |
| Bupropion Xl | Bupropion Hcl | 240 | 24 |
| Amiodarone Hcl | Amiodarone Hcl | 237 | 31 |
| Propranolol Hcl | Propranolol Hcl | 230 | 14 |
| Paroxetine Hcl | Paroxetine Hcl | 220 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 216 | 25 |
| Risperidone | Risperidone | 215 | 26 |
| Divalproex Sodium | Divalproex Sodium | 201 | 25 |
| Solifenacin Succinate | Solifenacin Succinate | 199 | 20 |
| Aripiprazole | Aripiprazole | 196 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 192 | 95 |
| Xifaxan | Rifaximin | 190 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 184 | 83 |
| Fluticasone Propionate | Fluticasone Propionate | 178 | 59 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 171 | 22 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 170 | 34 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 162 | 34 |
| Alendronate Sodium | Alendronate Sodium | 160 | 23 |
| Warfarin Sodium | Warfarin Sodium | 159 | 14 |
| Lactulose | Lactulose | 158 | 23 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 153 | 18 |
| Bupropion Hcl Sr | Bupropion Hcl | 150 | 14 |
| Topiramate | Topiramate | 150 | 11 |
| Entresto | Sacubitril/Valsartan | 143 | 15 |
| Nortriptyline Hcl | Nortriptyline Hcl | 139 | suppressed |
| Cephalexin | Cephalexin | 137 | 83 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 137 | 30 |
| Olanzapine | Olanzapine | 136 | 17 |
| Amitriptyline Hcl | Amitriptyline Hcl | 135 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 134 | 37 |
| Benztropine Mesylate | Benztropine Mesylate | 131 | suppressed |
| Sucralfate | Sucralfate | 130 | 21 |
| Trulicity | Dulaglutide | 130 | 22 |
| Diltiazem Hcl | Diltiazem Hcl | 129 | 12 |
| Propranolol Hcl Er | Propranolol Hcl | 129 | suppressed |
| Glipizide | Glipizide | 127 | 16 |
| Bupropion Hcl | Bupropion Hcl | 126 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 121 | 38 |
| Flecainide Acetate | Flecainide Acetate | 115 | suppressed |
| Xarelto | Rivaroxaban | 114 | 11 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 111 | 68 |
| Pravastatin Sodium | Pravastatin Sodium | 111 | 26 |
| Clonidine Hcl | Clonidine Hcl | 107 | 24 |
| Midodrine Hcl | Midodrine Hcl | 107 | 23 |
| Baclofen | Baclofen | 106 | 15 |
| Oxcarbazepine | Oxcarbazepine | 104 | suppressed |
| Brilinta | Ticagrelor | 103 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 103 | 37 |
| Nystatin | Nystatin | 103 | 53 |
| Acetazolamide | Acetazolamide | 102 | suppressed |
| Ozempic | Semaglutide | 95 | 18 |
| Lamotrigine | Lamotrigine | 92 | 11 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 89 | 86 |
| Metoclopramide Hcl | Metoclopramide Hcl | 88 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 86 | suppressed |
| Ezetimibe | Ezetimibe | 85 | 11 |
| Nifedipine Er | Nifedipine | 85 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 83 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 83 | 19 |
| Insulin Lispro | Insulin Lispro | 82 | 37 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 81 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 79 | 52 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 78 | 33 |
| Methotrexate | Methotrexate Sodium | 77 | suppressed |
| Primidone | Primidone | 77 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 77 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 76 | 54 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 75 | suppressed |
| Latanoprost | Latanoprost | 75 | 17 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 74 | 16 |
| Loperamide | Loperamide Hcl | 74 | 35 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 73 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 72 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 71 | 57 |
| Raloxifene Hcl | Raloxifene Hcl | 71 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 71 | 18 |
| Liothyronine Sodium | Liothyronine Sodium | 69 | suppressed |
| Cilostazol | Cilostazol | 68 | suppressed |
| Meloxicam | Meloxicam | 67 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 65 | 27 |
| Fluconazole | Fluconazole | 65 | 18 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 64 | suppressed |
| Novolog Flexpen | Insulin Aspart | 63 | 11 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 61 | 11 |
| Metolazone | Metolazone | 60 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 60 | suppressed |
| Dexamethasone | Dexamethasone | 59 | 43 |
| Januvia | Sitagliptin Phosphate | 59 | 15 |
| Alprazolam | Alprazolam | 56 | 16 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 56 | 21 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 56 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 55 | suppressed |
| Leflunomide | Leflunomide | 54 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 53 | 40 |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 52 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 52 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 51 | 12 |
| Glipizide Er | Glipizide | 50 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 50 | suppressed |
| Fenofibrate | Fenofibrate | 49 | 13 |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 49 | 36 |
| Zolpidem Tartrate | Zolpidem Tartrate | 49 | suppressed |
| Amantadine | Amantadine Hcl | 48 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 48 | 38 |
| Valsartan | Valsartan | 48 | suppressed |
| Acetylcysteine | Acetylcysteine | 47 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 47 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 47 | suppressed |
| Methylprednisolone | Methylprednisolone | 47 | 43 |
| Pregabalin | Pregabalin | 47 | suppressed |
| Ursodiol | Ursodiol | 47 | suppressed |
| Phenytoin | Phenytoin | 45 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 45 | 11 |
| Amoxicillin | Amoxicillin | 44 | 19 |
| Cinacalcet Hcl | Cinacalcet Hcl | 44 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 44 | 28 |
| Glimepiride | Glimepiride | 43 | suppressed |
| Lubiprostone | Lubiprostone | 43 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 43 | 21 |
| Azithromycin | Azithromycin | 42 | 36 |
| Roflumilast | Roflumilast | 42 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 41 | suppressed |
| Ondansetron Odt | Ondansetron | 41 | 30 |
| Theophylline Er | Theophylline Anhydrous | 40 | suppressed |
| Calcitriol | Calcitriol | 39 | suppressed |
| Konvomep | Omeprazole/Sodium Bicarbonate | 39 | suppressed |
| Simvastatin | Simvastatin | 39 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 38 | suppressed |
| Calcium Acetate | Calcium Acetate | 37 | suppressed |
| Nitroglycerin | Nitroglycerin | 37 | 32 |
| Humalog | Insulin Lispro | 36 | 11 |
| Humalog Kwikpen U-100 | Insulin Lispro | 36 | 13 |
| Levofloxacin | Levofloxacin | 36 | 31 |
| Oxybutynin Chloride | Oxybutynin Chloride | 36 | suppressed |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 35 | suppressed |
| Pentoxifylline | Pentoxifylline | 35 | suppressed |
| Rivastigmine | Rivastigmine | 35 | suppressed |
| Nystop | Nystatin | 34 | 17 |
| Sotalol | Sotalol Hcl | 34 | suppressed |
| Clozapine | Clozapine | 33 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 33 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 33 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 33 | suppressed |
| Budesonide | Budesonide | 32 | suppressed |
| Carbamazepine | Carbamazepine | 32 | suppressed |
| Celecoxib | Celecoxib | 32 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 32 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 32 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 31 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 31 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 31 | suppressed |
| Restasis | Cyclosporine | 31 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 30 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 29 | suppressed |
| Atenolol | Atenolol | 27 | suppressed |
| Cefdinir | Cefdinir | 26 | 25 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 26 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 26 | suppressed |
| Carbamazepine Er | Carbamazepine | 25 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 25 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 25 | suppressed |
| Armour Thyroid | Thyroid,pork | 24 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 24 | suppressed |
| Clonidine | Clonidine | 24 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 24 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 24 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 23 | suppressed |
| Teriflunomide | Teriflunomide | 23 | suppressed |
| Velphoro | Sucroferric Oxyhydroxide | 23 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 23 | 11 |
| Bethanechol Chloride | Bethanechol Chloride | 22 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 22 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 21 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 21 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 21 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 21 | suppressed |
| Methimazole | Methimazole | 21 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 21 | 17 |
| Theophylline | Theophylline Anhydrous | 21 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 21 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 20 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 20 | 15 |
| Mupirocin | Mupirocin | 20 | 16 |
| Atropine Sulfate | Atropine Sulfate | 19 | 17 |
| Dapagliflozin | Dapagliflozin Propanediol | 19 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 19 | suppressed |
| Synthroid | Levothyroxine Sodium | 19 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 19 | suppressed |
| Admelog | Insulin Lispro | 18 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 18 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 18 | suppressed |
| Linzess | Linaclotide | 18 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 17 | 16 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 17 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 17 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 17 | suppressed |
| Timolol Maleate | Timolol Maleate | 17 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 16 | suppressed |
| Estradiol | Estradiol | 16 | 11 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 16 | suppressed |
| Klayesta | Nystatin | 16 | suppressed |
| Meropenem | Meropenem | 16 | suppressed |
| Metronidazole | Metronidazole | 16 | 15 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 15 | suppressed |
| Creon | Lipase/Protease/Amylase | 15 | suppressed |
| Insulin Aspart | Insulin Aspart | 15 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 15 | suppressed |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 15 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 14 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 14 | suppressed |
| Klor-Con M20 | Potassium Chloride | 14 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 14 | suppressed |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 14 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 14 | suppressed |
| Trimethoprim | Trimethoprim | 14 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 14 | suppressed |
| Alogliptin | Alogliptin Benzoate | 13 | suppressed |
| Ketoconazole | Ketoconazole | 13 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 13 | suppressed |
| Myrbetriq | Mirabegron | 13 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 13 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 13 | suppressed |
| Rexulti | Brexpiprazole | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Ertapenem | Ertapenem Sodium | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Novolog Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 12 | suppressed |
| Scopolamine | Scopolamine | 12 | suppressed |
| Arformoterol Tartrate | Arformoterol Tartrate | 11 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 11 | suppressed |
| Clotrimazole | Clotrimazole | 11 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Humalog Kwikpen U-200 | Insulin Lispro | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $137.08 · 7 records | Vanda Pharmaceuticals Inc. | CAMZYOS, FANAPT, Fibroscan, VRAYLAR, WINREVAIR | 6 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error